The global Drug-Device Combination Products market size was valued at US$ 34430 million in 2023. With growing demand in downstream market, the Drug-Device Combination Products is forecast to a readjusted size of US$ 53420 million by 2030 with a CAGR of 6.5% during review period.
The research report highlights the growth potential of the global Drug-Device Combination Products market. Drug-Device Combination Products are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Drug-Device Combination Products. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Drug-Device Combination Products market.
Combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products, leading to safer and more effective treatments thanks to careful and precise drug targeting, local administration and individualized therapy. These technologies can especially benefit patients suffering from serious diseases and conditions such as cancer, heart disease, multiple sclerosis and diabetes, among others. On the other hand, drug-device combination products have also introduced a new dynamic in medical product development, regulatory approval and corporate interaction.
Global key drug-device combination products players include GSK, Novo Nordisk and Eli Lilly etc. The top 3 companies hold a share about 32%. North America is the largset market with a share about 42%, followed by Europe and Asia-Pacific.
In terms of product, nebulizer & inhaler is the largest segment with a share about 36%. And in terms of applications, the largset application is hospital and clinic with a share about 47%.
Key Features:
The report on Drug-Device Combination Products market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Drug-Device Combination Products market. It may include historical data, market segmentation by Type (e.g., Drug-Coated Device, Prefilled Drug Delivery Systems), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Drug-Device Combination Products market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Drug-Device Combination Products market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Drug-Device Combination Products industry. This include advancements in Drug-Device Combination Products technology, Drug-Device Combination Products new entrants, Drug-Device Combination Products new investment, and other innovations that are shaping the future of Drug-Device Combination Products.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Drug-Device Combination Products market. It includes factors influencing customer ' purchasing decisions, preferences for Drug-Device Combination Products product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Drug-Device Combination Products market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Drug-Device Combination Products market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Drug-Device Combination Products market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Drug-Device Combination Products industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Drug-Device Combination Products market.
Market Segmentation:
Drug-Device Combination Products market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Drug-Coated Device
Prefilled Drug Delivery Systems
Nebulizer and Inhaler
Transdermal Delivery System
Others
Segmentation by application
Hospital andClinic
Retail Pharmacies
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GSK
Novo Nordisk
Eli Lilly
AstraZeneca
Sanofi
Boston Scientific
Abbott
Boehringer Ingelheim
Medtronic
Mylan
3M
Hisamitsu
Smith & Nephew
Molnlycke
Teleflex
BD
Lepu Medical
MicroPort
Terumo
B. Braun
Antares Pharma
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug-Device Combination Products Market Size 2019-2030
2.1.2 Drug-Device Combination Products Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Drug-Device Combination Products Segment by Type
2.2.1 Drug-Coated Device
2.2.2 Prefilled Drug Delivery Systems
2.2.3 Nebulizer and Inhaler
2.2.4 Transdermal Delivery System
2.2.5 Others
2.3 Drug-Device Combination Products Market Size by Type
2.3.1 Drug-Device Combination Products Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Drug-Device Combination Products Market Size Market Share by Type (2019-2024)
2.4 Drug-Device Combination Products Segment by Application
2.4.1 Hospital andClinic
2.4.2 Retail Pharmacies
2.4.3 Other
2.5 Drug-Device Combination Products Market Size by Application
2.5.1 Drug-Device Combination Products Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Drug-Device Combination Products Market Size Market Share by Application (2019-2024)
3 Drug-Device Combination Products Market Size by Player
3.1 Drug-Device Combination Products Market Size Market Share by Players
3.1.1 Global Drug-Device Combination Products Revenue by Players (2019-2024)
3.1.2 Global Drug-Device Combination Products Revenue Market Share by Players (2019-2024)
3.2 Global Drug-Device Combination Products Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug-Device Combination Products by Regions
4.1 Drug-Device Combination Products Market Size by Regions (2019-2024)
4.2 Americas Drug-Device Combination Products Market Size Growth (2019-2024)
4.3 APAC Drug-Device Combination Products Market Size Growth (2019-2024)
4.4 Europe Drug-Device Combination Products Market Size Growth (2019-2024)
4.5 Middle East & Africa Drug-Device Combination Products Market Size Growth (2019-2024)
5 Americas
5.1 Americas Drug-Device Combination Products Market Size by Country (2019-2024)
5.2 Americas Drug-Device Combination Products Market Size by Type (2019-2024)
5.3 Americas Drug-Device Combination Products Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug-Device Combination Products Market Size by Region (2019-2024)
6.2 APAC Drug-Device Combination Products Market Size by Type (2019-2024)
6.3 APAC Drug-Device Combination Products Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug-Device Combination Products by Country (2019-2024)
7.2 Europe Drug-Device Combination Products Market Size by Type (2019-2024)
7.3 Europe Drug-Device Combination Products Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug-Device Combination Products by Region (2019-2024)
8.2 Middle East & Africa Drug-Device Combination Products Market Size by Type (2019-2024)
8.3 Middle East & Africa Drug-Device Combination Products Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug-Device Combination Products Market Forecast
10.1 Global Drug-Device Combination Products Forecast by Regions (2025-2030)
10.1.1 Global Drug-Device Combination Products Forecast by Regions (2025-2030)
10.1.2 Americas Drug-Device Combination Products Forecast
10.1.3 APAC Drug-Device Combination Products Forecast
10.1.4 Europe Drug-Device Combination Products Forecast
10.1.5 Middle East & Africa Drug-Device Combination Products Forecast
10.2 Americas Drug-Device Combination Products Forecast by Country (2025-2030)
10.2.1 United States Drug-Device Combination Products Market Forecast
10.2.2 Canada Drug-Device Combination Products Market Forecast
10.2.3 Mexico Drug-Device Combination Products Market Forecast
10.2.4 Brazil Drug-Device Combination Products Market Forecast
10.3 APAC Drug-Device Combination Products Forecast by Region (2025-2030)
10.3.1 China Drug-Device Combination Products Market Forecast
10.3.2 Japan Drug-Device Combination Products Market Forecast
10.3.3 Korea Drug-Device Combination Products Market Forecast
10.3.4 Southeast Asia Drug-Device Combination Products Market Forecast
10.3.5 India Drug-Device Combination Products Market Forecast
10.3.6 Australia Drug-Device Combination Products Market Forecast
10.4 Europe Drug-Device Combination Products Forecast by Country (2025-2030)
10.4.1 Germany Drug-Device Combination Products Market Forecast
10.4.2 France Drug-Device Combination Products Market Forecast
10.4.3 UK Drug-Device Combination Products Market Forecast
10.4.4 Italy Drug-Device Combination Products Market Forecast
10.4.5 Russia Drug-Device Combination Products Market Forecast
10.5 Middle East & Africa Drug-Device Combination Products Forecast by Region (2025-2030)
10.5.1 Egypt Drug-Device Combination Products Market Forecast
10.5.2 South Africa Drug-Device Combination Products Market Forecast
10.5.3 Israel Drug-Device Combination Products Market Forecast
10.5.4 Turkey Drug-Device Combination Products Market Forecast
10.5.5 GCC Countries Drug-Device Combination Products Market Forecast
10.6 Global Drug-Device Combination Products Forecast by Type (2025-2030)
10.7 Global Drug-Device Combination Products Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Drug-Device Combination Products Product Offered
11.1.3 GSK Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 GSK Main Business Overview
11.1.5 GSK Latest Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Information
11.2.2 Novo Nordisk Drug-Device Combination Products Product Offered
11.2.3 Novo Nordisk Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novo Nordisk Main Business Overview
11.2.5 Novo Nordisk Latest Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Drug-Device Combination Products Product Offered
11.3.3 Eli Lilly Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Eli Lilly Main Business Overview
11.3.5 Eli Lilly Latest Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Information
11.4.2 AstraZeneca Drug-Device Combination Products Product Offered
11.4.3 AstraZeneca Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 AstraZeneca Main Business Overview
11.4.5 AstraZeneca Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Drug-Device Combination Products Product Offered
11.5.3 Sanofi Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 Boston Scientific
11.6.1 Boston Scientific Company Information
11.6.2 Boston Scientific Drug-Device Combination Products Product Offered
11.6.3 Boston Scientific Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Boston Scientific Main Business Overview
11.6.5 Boston Scientific Latest Developments
11.7 Abbott
11.7.1 Abbott Company Information
11.7.2 Abbott Drug-Device Combination Products Product Offered
11.7.3 Abbott Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Abbott Main Business Overview
11.7.5 Abbott Latest Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Information
11.8.2 Boehringer Ingelheim Drug-Device Combination Products Product Offered
11.8.3 Boehringer Ingelheim Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Boehringer Ingelheim Main Business Overview
11.8.5 Boehringer Ingelheim Latest Developments
11.9 Medtronic
11.9.1 Medtronic Company Information
11.9.2 Medtronic Drug-Device Combination Products Product Offered
11.9.3 Medtronic Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Medtronic Main Business Overview
11.9.5 Medtronic Latest Developments
11.10 Mylan
11.10.1 Mylan Company Information
11.10.2 Mylan Drug-Device Combination Products Product Offered
11.10.3 Mylan Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Mylan Main Business Overview
11.10.5 Mylan Latest Developments
11.11 3M
11.11.1 3M Company Information
11.11.2 3M Drug-Device Combination Products Product Offered
11.11.3 3M Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 3M Main Business Overview
11.11.5 3M Latest Developments
11.12 Hisamitsu
11.12.1 Hisamitsu Company Information
11.12.2 Hisamitsu Drug-Device Combination Products Product Offered
11.12.3 Hisamitsu Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Hisamitsu Main Business Overview
11.12.5 Hisamitsu Latest Developments
11.13 Smith & Nephew
11.13.1 Smith & Nephew Company Information
11.13.2 Smith & Nephew Drug-Device Combination Products Product Offered
11.13.3 Smith & Nephew Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Smith & Nephew Main Business Overview
11.13.5 Smith & Nephew Latest Developments
11.14 Molnlycke
11.14.1 Molnlycke Company Information
11.14.2 Molnlycke Drug-Device Combination Products Product Offered
11.14.3 Molnlycke Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Molnlycke Main Business Overview
11.14.5 Molnlycke Latest Developments
11.15 Teleflex
11.15.1 Teleflex Company Information
11.15.2 Teleflex Drug-Device Combination Products Product Offered
11.15.3 Teleflex Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Teleflex Main Business Overview
11.15.5 Teleflex Latest Developments
11.16 BD
11.16.1 BD Company Information
11.16.2 BD Drug-Device Combination Products Product Offered
11.16.3 BD Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 BD Main Business Overview
11.16.5 BD Latest Developments
11.17 Lepu Medical
11.17.1 Lepu Medical Company Information
11.17.2 Lepu Medical Drug-Device Combination Products Product Offered
11.17.3 Lepu Medical Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Lepu Medical Main Business Overview
11.17.5 Lepu Medical Latest Developments
11.18 MicroPort
11.18.1 MicroPort Company Information
11.18.2 MicroPort Drug-Device Combination Products Product Offered
11.18.3 MicroPort Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 MicroPort Main Business Overview
11.18.5 MicroPort Latest Developments
11.19 Terumo
11.19.1 Terumo Company Information
11.19.2 Terumo Drug-Device Combination Products Product Offered
11.19.3 Terumo Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Terumo Main Business Overview
11.19.5 Terumo Latest Developments
11.20 B. Braun
11.20.1 B. Braun Company Information
11.20.2 B. Braun Drug-Device Combination Products Product Offered
11.20.3 B. Braun Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 B. Braun Main Business Overview
11.20.5 B. Braun Latest Developments
11.21 Antares Pharma
11.21.1 Antares Pharma Company Information
11.21.2 Antares Pharma Drug-Device Combination Products Product Offered
11.21.3 Antares Pharma Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Antares Pharma Main Business Overview
11.21.5 Antares Pharma Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
